Clinical Trials Logo

Clinical Trial Summary

The study is being conducted to evaluate the efficacy, and safety of HR18034 for postoperative analgesia in subjects undergoing hemorrhoidectomy. To explore the reasonable dosage of HR18034 for postoperative analgesia in subjects undergoing hemorrhoidectomy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05376904
Study type Interventional
Source Shanghai Hengrui Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 2
Start date June 13, 2022
Completion date October 5, 2022

See also
  Status Clinical Trial Phase
Completed NCT05769855 - A Study of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy Phase 3
Active, not recruiting NCT04699175 - A Trial of HR021618 in Postsurgical Pain Management Phase 2
Not yet recruiting NCT05161637 - Phase 2/3 Study of TLC590 for Postsurgical Pain Management Phase 2/Phase 3